Simulations Plus, Inc. (SLP): Price and Financial Metrics
Simulations Plus, Inc. (SLP)
Today's Latest Price: $49.96 USD
Updated Jun 5 11:37am
Add SLP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 47 in Software - Business
See all "A" rated Strong Buy stocks
SLP Stock Summary
- SLP's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 702.14 -- higher than 94.69% of US-listed equities with positive expected earnings growth.
- The price/operating cash flow metric for Simulations Plus Inc is higher than 96.96% of stocks in our set with a positive cash flow.
- SLP's price/sales ratio is 22.5; that's higher than the P/S ratio of 93.88% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Simulations Plus Inc are OMCL, ECOM, SPSC, IRMD, and NTIC.
- SLP's SEC filings can be seen here. And to visit Simulations Plus Inc's official web site, go to www.simulations-plus.com.
SLP Stock Price Chart More Charts
SLP Price/Volume Stats
| Current price | $49.96 | 52-week high | $53.76 |
| Prev. close | $47.76 | 52-week low | $24.84 |
| Day low | $47.63 | Volume | 63,494 |
| Day high | $50.30 | Avg. volume | 190,350 |
| 50-day MA | $39.71 | Dividend yield | 0.5% |
| 200-day MA | $35.41 | Market Cap | 887.69M |
Simulations Plus, Inc. (SLP) Company Bio
Simulations Plus develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The company was founded in 1996 and is based in Lancaster, California.
SLP Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $49.96 | $42.19 | -15% |
Below please find a table outlining a discounted cash flow forecast for SLP, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Simulations Plus Inc ranked in the 45th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 14.67%. In terms of the factors that were most noteworthy in this DCF analysis for SLP, they are:
- The company has produced more trailing twelve month cash flow than only 15.41% of its sector Technology.
- The business' balance sheet reveals debt to be 0% of the company's capital (with equity being the remaining amount). Approximately just 1.94% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- SLP's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 64.51% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -17% |
| 1% | -16% |
| 2% | -15% |
| 3% | -14% |
| 4% | -13% |
| 5% | -13% |
For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as SLP, try KLAC, MTCH, NVDA, RMBS, and UI.
Loading social stream, please wait...